ANTIGENICS INC (AGEN) 0.90 -$0.06 (-6.25%) 06:23PM (15 mins delay)

Dendreon: New Board Members Appointed, Things Have Never Looked Brighter

Oct 12, 2009 - 5:41 PM EDT

VFC submits:

Shares of Dendreon (DNDN) traded higher by nearly eight percent during early trading on Monday after it became apparent that the company had recently appointed two new members to its Board of Directors, one being the Chief Executive of Genentech, Ian Clark and the other being Pedro Granadillo, a one time executive for Eli Lilly & Co.

The appointment of Clark has fueled speculation that a partnership deal (with Roche) is imminent since Genentech is wholly-owned by Roche after a recent merger between the two companies. The DNDN stock price has now approached the thirty dollar level, most likely the result of speculation after the board appointments - in my opinion.

Complete Story »

Source: Seeking Alpha (Oct 12, 2009 - 5:41 PM EDT)